COMMUNIQUÉS West-GlobeNewswire

Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility
12/02/2019
VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into an agreement [...]
SELLAS Life Sciences Provides Galinpepimut-S and Nelipepimut-S Program Update
12/02/2019
Dr. Richard Maziarz and Dr. Roisin O'Cearbhaill Named Co-Principal Investigators for Galinpepimut-S (GPS) – Pembrolizumab Phase 1/2 Basket Trial Immune Response Data from the Phase 2b Nelipepimut-S (NPS) plus [...]
Teladoc Health to Announce Fourth Quarter and Full-Year 2018 Financial Results
12/02/2019
PURCHASE, NY, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release fourth quarter and full-year 2018 results on Wednesday, [...]
Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019
12/02/2019
Leading Gastrointestinal Disease Expert to Address Unmet Medical Need in Lactose Intolerance and the Potential of Phase 3 Drug Candidate RP-G28 LOS ANGELES, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc [...]
Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019
12/02/2019
CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]
Genocea Announces Private Placement Financing of Up to $39 Million
12/02/2019
CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has entered into a [...]
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update
12/02/2019
NOVATO, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.
12/02/2019
Designed specifically for the outward body shapes – and the first of its kind in the ostomy market – the new SenSura® Mio Convex Flip is now available in the United States. All bodies are different, and it is a [...]
Medexus Lists October 2018 Unsecured Convertible Debentures on the TSX Venture Exchange
12/02/2019
MONTREAL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced that the 6.0% unsecured convertible debentures of the Company [...]
WW Schedules Fourth Quarter and Full Year 2018 Earnings Conference Call
12/02/2019
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (NASDAQ: WTW) (“WW”) will release its results for the fourth quarter and full year 2018 after market close on Tuesday, February 26, 2019. [...]
IRIDEX Announces Resolution of its Dispute with Quantel Medical
12/02/2019
MOUNTAIN VIEW, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has resolved its differences with Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. ( [...]
Progressive Care Inc. Announces CEO, Shital Mars as Keynote Speaker at Cold Chain Global Forum in Toronto, Canada
12/02/2019
MIAMI, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that CEO, Shital Mars will be the keynote speaker at Cold Chain [...]
BioSig Technologies Inc. Issues 2019 Shareholder Letter
12/02/2019
Company provides updates on recent developments and highlights plans for future growth Santa Monica, CA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
12/02/2019
Provides Funding to Support Ongoing Activities Including Inventory Ramp, Plant Expansion, Product Launch and Plasma Collection Center Development RAMSEY, N.J. and BOCA RATON, Fla., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ADMA [...]
Loop Industries Completes and Expands Supply Agreement With Danone for 100% Sustainable PET
12/02/2019
MONTREAL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: Loop) (“Loop” or the “Company”), a leading technology innovator in sustainable plastic for packaging, today announced that it has completed a [...]
Spark Therapeutics to Host Conference Call on Tuesday, Feb. 19 at 8:30 a.m. ET to Discuss 2018 Results and Recent Business Highlights
12/02/2019
PHILADELPHIA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, will host a [...]
Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan in Patients with Decompensated NASH Cirrhosis
12/02/2019
SAN DIEGO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced the completion of enrollment in ENCORE-LF, a Phase 2b clinical trial evaluating emricasan, the company’s first-in- [...]
Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
12/02/2019
Canntab enters into 3-way supply agreement to purchase up to 1,000 kg of 2018 hemp crop TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab”), a leader in the [...]
Parkinson’s Disease: ProMIS Neurosciences Identifies Several Antibody Drug Candidates Showing Best-in-Class Selectivity for Toxic Forms of Alpha-Synuclein Compared to other Therapeutic Antibodies in Development
12/02/2019
Competitive Differentiation of ProMIS Antibodies is Key to Ongoing Partnering Discussions with Large Pharmaceutical Companies TORONTO and CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ( [...]

Pages